Study Details
The Alzheimer’s Plasma Extension Study is an observational study designed to capture longitudinal follow-up of plasma biomarkers and cognitive and functional assessments on individuals who screen failed in the AHEAD study over approximately 4 years. https://www.actcinfo.org/alzheimers-plasma-extension-apex-study/ Only individuals who participated in screening for the AHEAD 3-45 Study are eligible to enroll in APEX. The site will contact you directly if you have been determined to be eligible. IRB number STU00219392 |